Trial NCT03131206

View at ClinicalTrials.gov 
Org. Study IDs: 17-080

Last trial update was posted on 2021-09-27

MeSH Interventions

Alectinib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms Thyroid Diseases Thyroid Neoplasms

Other Conditions

ALK-positive Non-small Cell Lung Cancer (NSCLC) RET-positive Non-small Cell Lung Cancer (NSCLC) RET-positive Thyroid Cancer

Stopping Reasons

Study closed due to slow accrual and lack of efficacy.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID